ArticleOncotarget2022

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer.

Sewanti Limaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.